| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$202,708,978 |
|
|
|
Indirect Value
|
$172,941,055 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$375,650,033 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 19 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-17 |
4 |
B |
$4.98 |
$369,152 |
I/I |
74,127 |
18,396,090 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-06-08 |
4 |
B |
$14.07 |
$369,647 |
I/I |
26,272 |
661,994 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2013-08-16 |
4 |
B |
$8.00 |
$369,968 |
I/I |
46,246 |
9,177,219 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-03-02 |
4 |
B |
$24.84 |
$372,600 |
I/I |
15,000 |
1,530,323 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-03-01 |
4 |
B |
$25.15 |
$377,250 |
I/I |
15,000 |
1,515,323 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-13 |
4 |
B |
$18.98 |
$379,600 |
I/I |
20,000 |
1,464,823 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-05-28 |
4 |
B |
$2.05 |
$381,787 |
D/D |
186,684 |
4,161,193 |
2.45 |
- |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2021-08-19 |
4 |
B |
$7.69 |
$384,440 |
I/I |
50,000 |
6,035,953 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-03-09 |
4 |
B |
$17.18 |
$387,993 |
I/I |
22,584 |
10,757,173 |
2.25 |
- |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-11-05 |
4 |
B |
$0.77 |
$389,600 |
I/I |
505,974 |
5,314,317 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-07-16 |
4 |
B |
$19.89 |
$397,800 |
I/I |
20,000 |
10,678,690 |
2.25 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2020-12-07 |
4 |
OE |
$6.83 |
$400,218 |
I/I |
58,597 |
5,725,419 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-13 |
4 |
B |
$4.03 |
$403,000 |
I/I |
100,000 |
18,663,916 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-12-13 |
4 |
OE |
$6.48 |
$407,023 |
I/I |
52,851 |
13,169,698 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-14 |
4 |
S |
$13.65 |
$411,677 |
D/D |
(29,900) |
2,690,525 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-05-27 |
4 |
B |
$2.06 |
$412,680 |
D/D |
200,000 |
3,974,509 |
2.45 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-03-04 |
4 |
S |
$2.62 |
$452,570 |
I/I |
(172,717) |
4,272,777 |
0 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-12 |
4 |
S |
$13.77 |
$456,498 |
D/D |
(33,134) |
2,939,562 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-10 |
4 |
B |
$18.81 |
$462,369 |
I/I |
24,581 |
1,444,823 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-11 |
4 |
A |
$13.83 |
$470,220 |
I/I |
34,000 |
1,749,423 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-03-07 |
4 |
B |
$14.62 |
$482,460 |
I/I |
33,000 |
37,067 |
2.1 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-09 |
4 |
B |
$18.54 |
$493,164 |
I/I |
26,600 |
1,420,242 |
2.25 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2010-06-10 |
4 |
B |
$10.70 |
$495,385 |
I/I |
46,305 |
587,906 |
2.1 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-08-15 |
4 |
B |
$0.65 |
$497,250 |
I/I |
765,000 |
1,637,956 |
0.01 |
% |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-10-22 |
4 |
B |
$0.92 |
$498,047 |
I/I |
541,355 |
4,721,022 |
1.5 |
- |
|
634 Records found
|
|
Page 19 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
